Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
One of Dana-Farber's main goals is to reduce cancer risk among local and regional communities who have been historically marginalized. We work with city and state health departments, community partners, and Boston-based coalitions to assess and monitor the needs of local residents with respect to cancer care and control.
We are on the front lines of supporting and collaborating on programs designed to eliminate disparities in breast, colon, and skin cancer; educate diverse populations about tobacco cessation, human papillomavirus (HPV) prevention and screening; and strengthen the support system for medically underserved populations.
At Dana-Farber, we are committed to:
Dana-Farber is dedicated to meeting the health needs of high-risk and medically underserved populations in our communities.
Addressing Cancer InequitiesDana-Farber's Chief Clinical Access and Equity Officer, Christopher Lathan, MD, MS, MPH, details health equity research that highlights key findings and recommendations on community outreach and engagement efforts of the National Comprehensive Cancer Centers.
In addition, Dana-Farber offers: